CRISPR Unlocks Sweeter Tomatoes Without Yield Loss
Carbon
Nov. 19, 2024
Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.
Always stay updated with the free CMN Newsletter.
ArtisanBio
Main focus: CRISPR-edited cellular therapies
Company stage: Pre-clinical
Diseases (gene editing): Cancer
Genome editing tool: CRISPR
Funding stage: Private
Location: Denver, Colorado, USA
Website: https://artisancells.com/
Pipeline: https://artisancells.com/portfolio/
Gene-editing partnerships: Multiple undisclosed
ArtisanBio develops CRISPR-engineered cellular therapies to treat various undisclosed types of cancers. The company combines CRISPR gene editing with high-throughput workflows and data analysis to enable multiplex engineering of cells. The company yet has to disclose the details of its lead pre-clinical programmes.
